FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382023243> ?p ?o ?g. }

• W4382023243 endingPage "6018" @default.
• W4382023243 startingPage "6006" @default.
• W4382023243 abstract "Concurrent chemoradiotherapy (CRT) is the standard of care for limited-stage small cell lung cancer (LS-SCLC). Local therapy—surgery or stereotactic body radiotherapy (SBRT)—with adjuvant chemotherapy may be appropriate for very early (T1-T2, N0) disease. There is variability in the management of these cases, which may lead to variability in patient outcomes. This study aimed to determine practice patterns for the management of very early LS-SCLC in Canada. A survey was developed and distributed to Canadian medical and radiation oncologists specialising in lung cancer. The survey consisted of three sections: (1) physician demographics, (2) general practice approach, and (3) preferred approach for three clinical scenarios (1: peripheral T1 lesion; 2: central T1 lesion; 3: peripheral T2 lesion). Responses were analysed to detect differences across cases and among physician groups. There were 77 respondents. In case 1, assuming medical operability, most respondents (73%) chose surgery and adjuvant chemotherapy, with 19% choosing CRT. CRT was selected by a higher proportion in case 2 (48%) and case 3 (61%) (p < 0.05). If medically inoperable, most chose CRT over local therapy in all cases, with more choosing CRT in case 2 (84%) and case 3 (86%) than in case 1 (55%) (p < 0.05). Subgroup analysis showed a predilection towards CRT in Western Canada and among more experienced physicians, and towards SBRT in Ontario. There is variability in the management of very early LS-SCLC in Canada. CRT remains the most popular strategy in most cases, with surgery preferred for small peripheral lesions. Larger and more central tumours are more likely to be managed with CRT. Variation in practice is correlated with region and physician experience. Our study illustrates the variability in the management of very early LS-SCLC in Canada and highlights the need for more robust investigations into the ideal approach for these patients." @default.
• W4382023243 created "2023-06-27" @default.
• W4382023243 creator A5039964937 @default.
• W4382023243 creator A5040448548 @default.
• W4382023243 creator A5052379271 @default.
• W4382023243 creator A5053114331 @default.
• W4382023243 date "2023-06-23" @default.
• W4382023243 modified "2023-10-14" @default.
• W4382023243 title "Management of Very Early Small Cell Lung Cancer: A Canadian Survey Study" @default.
• W4382023243 cites W2029854747 @default.
• W4382023243 cites W2074552727 @default.
• W4382023243 cites W2150713507 @default.
• W4382023243 cites W2169848988 @default.
• W4382023243 cites W2339444986 @default.
• W4382023243 cites W2528776163 @default.
• W4382023243 cites W2548496660 @default.
• W4382023243 cites W2549434555 @default.
• W4382023243 cites W2601338263 @default.
• W4382023243 cites W2815764189 @default.
• W4382023243 cites W2904870286 @default.
• W4382023243 cites W3012661873 @default.
• W4382023243 cites W3183328865 @default.
• W4382023243 cites W4200430299 @default.
• W4382023243 cites W4200477716 @default.
• W4382023243 doi "https://doi.org/10.3390/curroncol30070449" @default.
• W4382023243 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37504310" @default.
• W4382023243 hasPublicationYear "2023" @default.
• W4382023243 type Work @default.
• W4382023243 citedByCount "0" @default.
• W4382023243 crossrefType "journal-article" @default.
• W4382023243 hasAuthorship W4382023243A5039964937 @default.
• W4382023243 hasAuthorship W4382023243A5040448548 @default.
• W4382023243 hasAuthorship W4382023243A5052379271 @default.
• W4382023243 hasAuthorship W4382023243A5053114331 @default.
• W4382023243 hasBestOaLocation W43820232431 @default.
• W4382023243 hasConcept C126322002 @default.
• W4382023243 hasConcept C141071460 @default.
• W4382023243 hasConcept C146357865 @default.
• W4382023243 hasConcept C151730666 @default.
• W4382023243 hasConcept C2776256026 @default.
• W4382023243 hasConcept C2778424827 @default.
• W4382023243 hasConcept C2781156865 @default.
• W4382023243 hasConcept C509974204 @default.
• W4382023243 hasConcept C512399662 @default.
• W4382023243 hasConcept C71924100 @default.
• W4382023243 hasConcept C86803240 @default.
• W4382023243 hasConceptScore W4382023243C126322002 @default.
• W4382023243 hasConceptScore W4382023243C141071460 @default.
• W4382023243 hasConceptScore W4382023243C146357865 @default.
• W4382023243 hasConceptScore W4382023243C151730666 @default.
• W4382023243 hasConceptScore W4382023243C2776256026 @default.
• W4382023243 hasConceptScore W4382023243C2778424827 @default.
• W4382023243 hasConceptScore W4382023243C2781156865 @default.
• W4382023243 hasConceptScore W4382023243C509974204 @default.
• W4382023243 hasConceptScore W4382023243C512399662 @default.
• W4382023243 hasConceptScore W4382023243C71924100 @default.
• W4382023243 hasConceptScore W4382023243C86803240 @default.
• W4382023243 hasIssue "7" @default.
• W4382023243 hasLocation W43820232431 @default.
• W4382023243 hasLocation W43820232432 @default.
• W4382023243 hasLocation W43820232433 @default.
• W4382023243 hasOpenAccess W4382023243 @default.
• W4382023243 hasPrimaryLocation W43820232431 @default.
• W4382023243 hasRelatedWork W2003938723 @default.
• W4382023243 hasRelatedWork W2047967234 @default.
• W4382023243 hasRelatedWork W2118496982 @default.
• W4382023243 hasRelatedWork W2277416945 @default.
• W4382023243 hasRelatedWork W2350068585 @default.
• W4382023243 hasRelatedWork W2364998975 @default.
• W4382023243 hasRelatedWork W2369162477 @default.
• W4382023243 hasRelatedWork W2439875401 @default.
• W4382023243 hasRelatedWork W4238867864 @default.
• W4382023243 hasRelatedWork W2525756941 @default.
• W4382023243 hasVolume "30" @default.
• W4382023243 isParatext "false" @default.
• W4382023243 isRetracted "false" @default.
• W4382023243 workType "article" @default.